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Abstract 
Background: Various studies have shown that plasma homocysteine serum levels are elevated 
in actively drinking alcohol dependent patients a during alcohol withdrawal, while rapidly 
declining during abstinence. Hyperhomocysteinaemia has been associated not only with blood 
alcohol concentration, but also with deficiency of different B-vitamins, particularly folate, 
pyridoxine and cobalamin.  
Methods: Our study included 168 inpatients (110 men, 58 women) after admission for 
detoxification treatment. Blood alcohol concentration, folate, cobalamin, pyridoxine, thiamine 
and riboflavin were obtained on admission (day 1). Homocysteine was assessed on days 1, 7 
and 11. 
Results: Homocysteine levels significantly declined during withdrawal. General linear models 
and linear regression analysis showed an influence of blood alcohol concentration, folate and 
riboflavin on the homocysteine levels on admission as well as on homocysteine changes 
occurring during alcohol withdrawal. No significant influence was found for thiamine, 
cobalamin and pyridoxine.   
Discussion: These findings show that not only blood alcohol concentration and plasma folate 
levels, but also plasma levels of riboflavin influence homocysteine plasma levels in alcohol 
dependent patients.  
 
 
Keywords: homocysteine, alcohol dependence, alcoholism, folate, withdrawal, riboflavine, 
MTHFR, B-vitamins
Introduction  
Homocysteine (HCY) metabolism is known to be fundamentally altered during alcohol 
intoxication and withdrawal (Bleich et al., 2005; Bleich et al., 2004; Bleich et al., 2000b). 
This has been shown for alcohol dependent patients, but also – to a lesser extent – for social 
drinkers (Bleich et al., 2001). HCY levels found in alcohol dependent patients tend to be 
much higher than the common cut-off levels for HCY, defined in a study of Ubbink and 
colleagues as 11.7mol/l (Ubbink et al., 1995) or in a different investigation as 11.4mol/l for 
male and 10.4mol/l for female subjects (Selhub et al., 1999). 
The amino acid HCY is known to increase glutamatergic neurotransmission via activation of 
the N-Methyl-D-Aspartate (NMDA)-receptor of the glutamatergic system (Bleich et al., 2004; 
Bleich and Hillemacher, 2009). The glutamatergic system is of crucial importance not only 
for withdrawal symptoms but also for the individual relapse risk and is targeted by, e.g., the 
anti-craving compound acamprosate (Hillemacher et al., 2007b; Umhau et al., 2010). Elevated 
homocysteine levels lead to neurodegeneration and have been associated – inter alia – with 
vascular diseases and brain atrophy (Sachdev, 2004; Wilhelm et al., 2008). During alcohol 
withdrawal neurotransmission via the (up-regulated) NMDA-receptors is not longer blocked 
by ethanol, resulting in an extensive overstimulation by HCY-associated NMDA-receptor 
agonism. This extensive glutamatergic reaction has been assumed to be the neurobiological 
background of the association between elevated HCY levels and the higher risk of alcohol 
withdrawal seizures (Bayerlein et al., 2005; Bleich et al., 2006; Bleich et al., 2000a; 
Hillemacher et al., 2007a). Furthermore, elevated HCY levels have been found to correlate 
with short-term cognition deficits during alcohol withdrawal (Wilhelm et al., 2006) as well as 
long-term cerebral atrophy (Bleich et al., 2003). 
This increase in HCY levels in alcohol dependent patients is based on direct effects of ethanol 
(Bleich et al., 2005; Bleich et al., 2000b) as well as an alcohol-associated deficiency of folate 
(vitamin B9), cobalamine (vitamin B12), pyridoxine (vitamin B6) (Bleich et al., 2004; Chen 
et al.; Cravo and Camilo, 2000). 
The present study was performed to validate previous findings investigating alterations of 
HCY serum levels during alcohol withdrawal in a large population of alcohol dependent 
patients and to study the role of the B-vitamins involved in homocysteine metabolism in the 
pathogenesis of alcohol-associated hyperhomocysteinemia.  
 
Subjects and methods 
The present study was part of the German Investigation on Neurobiology in Alcoholism 
(GINA). All patients were recruited from the Department of Addiction and Psychotherapy of 
the hospital "Rheinische Kliniken" in Bonn, Germany. Written informed consent was 
obtained from all 363 patients (251 men, 112 women). In a subsample of serial patients, we 
performed a prospective approach, obtaining data on day 1, day 7 and day 11 after admission 
for detoxification treatment. This subsample was used in the present analysis, consisting of 
168 patients (110 men, 58 women). All procedures were approved by the local ethics 
committee of the University of Bonn, Germany, and were in accordance with the Helsinki 
Declaration of 1975, as revised in 1983. All participants suffered from alcohol dependency 
according to ICD-10 and were included in the study on admission for alcohol detoxification. 
Patients were mainly detoxified using clomethiazole following a symptom-triggered regime 
using the Banger-Score (Banger et al., 1992). If, for clinical reasons, clomethiazole could not 
be used, benzodiazepines were administered. Patients suffering from dependence of other 
substances except alcohol and nicotine were excluded from the study.  
 
Laboratory measurements: 
Fasting blood samples were obtained on day 1 (admission), day 7 and day 11 of detoxification 
treatment. Blood samples were centrifuged and consecutive serum and lithium heparin plasma 
samples were stored at -80ºC directly after collection. HCY was assessed at all three time 
points while vitamin serum levels were obtained at admission. 
Plasma total HCY concentrations were measured by means of particle-enhanced 
immunonephelometry with a Dimension Vista™ system according to the manufacturer’s 
instructions (Siemens Healthcare Diagnostics, Eschborn, Germany). The reference interval 
given by Siemens Healthcare Diagnostics was 4.9-15.0 µmol/l. Serum vitamin B12 and folate 
concentrations were measured by means of a homogenous, competitive chemiluminescent 
immunoassay based on the LOCI™ technology with a Dimension Vista™ system (Siemens 
Healthcare Diagnostics, Eschborn, Germany). Reference intervals given by Siemens 
Healthcare Diagnostics were 3.1-17.5 ng/ml for folate and 254–1320 pg/ml for cobalamin. 
Serum alcohol concentration was measured by means of an enzymatic test (alcohol 
dehydrogenase method) with a Dimension Vista™ system (Siemens Healthcare Diagnostics). 
Blood concentrations of thiamine, riboflavin and pyridoxine were analyzed using 
commercially available HPLC assays (Chromsystems Instruments & Chemicals GmbH, 
Munich, Germany) on a HPLC system with a fluorescence detector (Agilent.Series 1200, 
Agilent, Waldbronn, Germany). Reference intervals given by Chromsystems were 66.5 – 200 
nnmol/l for thiamine, 174 – 471 nmol/l for riboflavin and 8.7 – 27.3 µg/l for pyridoxine. 
 
 
Statistical assessment:  
Results are presented as mean plus standard deviation (SD) or standard error (SE). Variables 
were normally distributed as tested using the Kolmogorov-Smirnov test. Linear regression 
models and general linear models for repeat measurements were used to test the influence of 
different variables on HCY levels. Significance level (p-value) was set below 0.05.  
Data were analyzed using IBM SPSS Statistics 19.0 and Graph Pad PrismTM 5.0 (Graph Pad 
Software Inc., San Diego, CA). 
 Results 
Demographic characteristics of the study population are given in Table 1. Very few patients 
suffered from a definitive B-vitamine deficiency (two patient presented folate deficiency, one 
patient thiamine deficiency, yet none of the other included B-vitamins). 
Statistical analysis using general linear models for repeat measurements showed that 
homocysteine levels decline rapidly during alcohol withdrawal (F=45.28, p<0.001), with 
significant differences between all time points (day 1/day7: p<0.001; day1/day11: p<0.001; 
day7/day11: p<0.001; Figure 1). A multivariate linear regression model showed that HCY 
serum levels on day 1 of alcohol withdrawal are significantly influenced by BAC on 
admission (B=1.60, T=2.30, p=0.022), folate (B=-0.75, T=-5.47, p<0.001) and riboflavin 
(B=-0.06, T=-3.44, p=0.001), but not by thiamine, pyridoxine or cobalamin serum levels. 
Correlation analysis revealed no significant association between folate and riboflavin levels 
(r=0.119, p=0.121). To test which factors influence the changes of HCY levels over time (day 
1, day 7, day 11), we performed a general linear model computing BAC and vitamin levels as 
covariates. We found a significant interaction between HCY changes over time and BAC on 
admission (F=4.80, p=0.009), folate serum levels on admission (F=7.02, p=0.001) and 
riboflavin serum levels on admission (F=3.228, p=0.042), but not with other tested variables 
(thiamine, pyridoxine or cobalamin). Including the interaction between folate and riboflavin 
and omitting thiamine, pyridoxine and cobalamin results did not relevantly differ regarding 
the influence of thiamine, riboflavin and BAC on changes of HCY over time without showing 
a significant effect of the interaction (folate/riboflavin: F=1.56, p=0.214). 
Comparing the subgroups of patients with high (HCY>15.35μmol/l, N=84) and low 
(HCY<=15.36μmol/l, N=84) HCY serum levels at admission, t-test for independent samples 
revealed that the high HCY group also showed significantly elevated HCY levels on day 7 
(T=6.4, p<0.001) and elevated HCY levels on day 11 (T=6.0, p<0.0001) as well as reduced 
folate (T=-6.3, p<0.001), riboflavin (T=-2.7, p=0.008) and pyridoxine (T=-2.1, p=0.039) 
serum levels at admission. 
 
Discussion 
The present investigation confirms previous observations that reported elevated HCY levels in 
patients with alcohol dependence undergoing detoxification treatment. As shown previously, 
on the time of admission the extent of the HCY serum levels depends significantly on BAC 
(Bleich et al., 2005; Bleich et al., 2000b). However, apart from BAC, serum levels of 
riboflavin and folate also showed a significant influence on HCY serum levels on admission. 
The same result was found when general linear model analysis was performed, analyzing the 
effect of BAC and B-vitamins on the changes of HCY during withdrawal. Interestingly, 
cobalamin and pyridoxine showed no significant influence on HCY. However, riboflavin, 
which, to our knowledge, has not been studied in the context of alcohol-associated 
hyperhomocysteinemia before, showed a significant impact on HCY levels, which did not 
depend on its interaction with folate. Riboflavin is a precursor of various flavin-coenzymes, 
particularly of the flavin adenine dinucleotide (FAD), which is a coenzyme of  
methylenetetrahydrofolate reductase MTHFR (Moat et al., 2003). Substituted by FAD 
MTHFR catalyses 5,10-methylenetetrafolate to 5-methylenetetrafolate, which is of 
importance as a donor of methyl groups for remethylation of homocysteine (Moat et al., 
2003). Accordingly, MTHFR activity is reduced in ribloflavin-deficient rats (Bates and Fuller, 
1986).   
Overall, our results show that apart from individual BAC folate and riboflavin plasma levels 
on admission contribute to HCY elevation in alcohol dependent patients. This effect was not 
only shown at the beginning of in-patient treatment but also regarding the decline of HCY 
during the withdrawal period. Noteworthy, only a negligible number of patients suffered from 
a definite B-vitamin deficiency. Thus, the present findings support the hypothesis that a 
supplementation of folate and riboflavin may be useful in alcohol dependent patients during 
active drinking as well as detoxification and that currently used reference values for B-
vitamins may need to be adjusted for alcohol dependent patients.  
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Table 1: Demographic characteristics of the study population 
 
 mean SD median range 
age (years) 48.1 8.7 48.0 21-66 
BAC (per mille) 1.46 1.1 1.43 0-4.2 
HCY day 1 (μmol/l) 19.6 12,9 15.3 5.5-94.9 
HCY day 7 (μmol/l) 12.9 5.9 11.6 5.1-55.9 
HCY day 11 (μmol/l) 11.9 5.1 10.7 0.2-50.4 
folate (ng/ml) 9.8 5.7 9.1 1.5-20.0 
riboflavin (nmol/l) 295.1 51.0 288.6 192.7-480.1 
thiamine (nmol/l) 164.4 47.1 160.9 16.8-338.6 
pyridoxine (μg/l) 31.4 48.9 25.1 10.6-522.6 
cobalamin (pg/ml) 705.7 293.8 650.0 228.0-1500.0 
Sex male: N=110 female: N=58 
 
Legend table 1: 
SD: standard deviation, BAC: blood alcohol concentration at admission; HCY: homocysteine 
serum levels, measured at day 1, day 7 or day 11 after admission for in-patients detoxification 
treatment. Vitamin levels were measured at admission.  
Figure 1: Decrease of homocysteine serum levels during alcohol withdrawal 
 
 
 
 
Legend Figure 1 
Box plot showing changes of homocysteine plasma levels during withdrawal. Box represents 
25-75 percentile, whiskers represent 5-95 percentile. Bar represents median, cross represents 
mean. Homocysteine plasma levels decreased significantly during the course of withdrawal. 
Statistical details are summarized in the results section. 
 
